Genomate Health Adds Intelligene Healthcare as India Distributor
Genomate Health Inc, a global leader in precision oncology, announces its strategic partnership with Intelligene Healthcare Pvt Ltd, marking a significant step towards advancing personalized...
Imagene Announces LungOI, the First AI-Based NSCLC Molecular Panel for Immediate Cancer Biomarker Profiling
Rapid NSCLC Biomarker Test already demonstrated its significant impact and clinical benefits as part of a lung cancer clinical study. Imagene, an emerging leader in...
Hoag Hospital and Imagene Partner to Empower Rapid Cancer Diagnosis for Personalized Cancer Care
Leveraging AI-based molecular profiling from a digitized biopsy image to enable physicians to gain immediate oncology intelligence. Hoag, the largest community-based healthcare system in southern...
Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology
The ImageneOI rapid AI-based biomarker profiling platform significantly improves lung cancer patient outcomes, as demonstrated by a recently published case report. Imagene, an emerging leader...
Two Patients Receive Immediate Targeted Therapy, Avert Brain Radiation
A groundbreaking case report publication on the impact of rapid molecular testing on lung cancer patientsTEL AVIV, ISRAEL / ACCESSWIRE / July 26, 2023 /...
Imagene’s AI-Based Molecular Profiling Revolutionizes Lung Cancer Diagnostics: Two Patients Receive Immediate Targeted Therapy, Avert Brain Radiation
A groundbreaking case report publication on the impact of rapid molecular testing on lung cancer patients Imagene, an emerging leader in AI-based precision oncology, is...
Imagene Wins Frost & Sullivan’s Technology Innovation Leadership Award for Its Revolutionary AI-Based Molecular Testing for Cancer Diagnosis
Imagene, an emerging leader in the field of AI-based precision oncology, is proud to announce its win of the Frost & Sullivan 2023 Europe Technology...